Literature DB >> 1366651

What should be focused in the study of cell culture technology for production of bioactive proteins.

H Murakami1.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1366651     DOI： 10.1007/bf00365260

Source DB:  PubMed          Journal:  Cytotechnology        ISSN： 0920-9069            Impact factor:   2.058


× No keyword cloud information.
  8 in total

1.  High cell density perfusion culture of hybridoma cells recycling high molecular weight components.

Authors:  Y Takazawa; M Tokashiki; K Hamamoto; H Murakami
Journal:  Cytotechnology       Date:  1988-02       Impact factor: 2.058

2.  An unstable intermediate carrying information from genes to ribosomes for protein synthesis.

Authors:  S BRENNER; F JACOB; M MESELSON
Journal:  Nature       Date:  1961-05-13       Impact factor: 49.962

Review 3.  Membrane immunoglobulins and antigen receptors on B and T lymphocytes.

Authors:  N L Warner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

4.  Replacement of serum by hormones permits growth of cells in a defined medium.

Authors:  I Hayashi; G H Sato
Journal:  Nature       Date:  1976-01-15       Impact factor: 49.962

5.  High density culture of mouse-human hybridoma cells using a perfusion culture apparatus with multi-settling zones to separate cells from the culture medium.

Authors:  M Tokashiki; T Arai
Journal:  Cytotechnology       Date:  1989-02       Impact factor: 2.058

6.  Stimulation of monoclonal antibody production by human-human hybridoma cells with an elevated concentration of potassium or sodium phosphate in serum-free medium.

Authors:  S Sato; H Murakami; T Sugahara; T Ikegami; K Yamada; H Omura; S Hashizume
Journal:  Cytotechnology       Date:  1989-02       Impact factor: 2.058

7.  Human hybrid immunoglobulin M containing immunoglobulin A.

Authors:  H Shinmoto; H Murakami; S Dosako; K Yamada; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1988-06

8.  Partial purification and characterization of immunoglobulin production stimulating factor derived from Namalwa cells.

Authors:  K Yamada; K Akiyoshi; H Murakami; T Sugahara; I Ikeda; K Toyoda; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1989-03
  8 in total
  8 in total

1.  Purification of immunoglobulin production stimulation factor II alpha derived from Namalwa cells.

Authors:  T Sugahara; S Shirahata; K Yamada; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

Review 2.  Strategies for optimising serum-free media.

Authors:  G Hewlett
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

3.  Increased antigen binding strengths of hybrid antibodies produced by human hybrid hybridomas.

Authors:  H Tachibana; S Shirahata; H Kawahara; H Murakami
Journal:  Cytotechnology       Date:  1991-09       Impact factor: 2.058

Review 4.  Physiological enhancement of immunoglobulin production of hybridomas in serum-free media.

Authors:  H Murakami; K Yamada; S Shirahata; A Enomoto; S Kaminogawa
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

Review 5.  Animal cells--the breakthrough to a dominant technology.

Authors:  B Griffiths
Journal:  Cytotechnology       Date:  1990-03       Impact factor: 2.058

6.  Introduction : Changing frontiers in cell culture engineering: Manipulating cell biology to improve process technology.

Authors:  M C Flickinger
Journal:  Cytotechnology       Date:  1992-02       Impact factor: 2.058

7.  Production of monoclonal antibodies against human chorionic gonadotropin by hybridoma cultures in calcium alginate capsules.

Authors:  D J Oh; S K Choi; H N Chang; T B Choe
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

8.  Effects of polyamines on proliferation and IgM productivity of human-human hybridoma, HB4C5 cells.

Authors:  Takuya Sugahara; Sogo Nishimoto; Yoshiyuki Miyazaki
Journal:  Cytotechnology       Date:  2007-12-21       Impact factor: 2.058
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.